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Summary.-When injected i.p. and in large numbers (107) into syngeneic mice,
125IUdR-labelled L1210 cells are rapidly destroyed in a small proportion of animals,
while in the other animals the lysis is low. This bimodal distribution is clearly visible
24 h after cell injection. The intense lysis occurs in fewer animals when macrophage-
derived lysosomal enzymes are inhibited by trypan blue and if the complement is
depleted by high doses of cobra venom factor (CVF). The intense destruction occurs
in more animals after adjuvant treatment, ifthe mice are latentlycontaminated, after
a moderate production of C3b by low doses of CVF, or after the injection of a tumour-
cell dialysate.
The destruction seems to be the result of positive feedback reaction which involves
at least macrophages and complement activation.
In vivo tumour-cell destruction can
be evaluated by a well established method
based on the measurement of the radio-
activity ofmice injected i.p. with 125IUdR-
labelled cells. The loss of 125J is a measure
of the proportion of labelled cells that
have been killed. In most animals of
the control groups, the rate of elimination
of the radioactivity is moderate, 15 °/5
per day, well in accord with the published
data (Hofer, Prensky and Hughes, 1969;
Porteous and Munro, 1972).
In a small number of animals, however,
an intense immediate destruction can
be observed, the frequency and the
intensity of which we attempted to
evaluate. The present paper reports some
results which could suggest a mechanism.
MATERIAL AND METHODS
Animals. Specific-pathogen-free mice 6
weeks old were purchased from the Centre
d'Elevage des Animaux du Laboratoire,
Orleans la Source; DBA/2 and DBA/2 x
C57BL/6 F1 (BDF1) hybrids were used.
They were then kept in conventional condi-
tions in our Institute and wvere used before
they were 10 weeks old.
Tumour cells. Labelled tumour-cell injec-
tion was carried out following the method
of Porteous and M1unro (1972). BDF1 mice
received i.p. 105 L1210 cells. Five days
later, 4 injections of 1 juCi 125IUdR were
given; on Day 7, the cells were harvested
in Hanks' solution with added heparin,
centrifuged, at 200 g in the cold, resuspended,
counted and adjusted to the appropriate
concentrations.
In order to minimize cell leakage at the
injection site, (12 x 0 4 mm) hypodermic
needles were used and inserted first s.c.,
then i.p. Uptake of the 1251 into the thyroid
was prevented by including 0-1% of potas-
sium iodide in the drinking water, starting
from 2 days before the injection of labelled
cells. The litter was changed every day
to reduce the ingestion of radioactive
sawdust.
Measuremnent of radioactivity.-Mice were
introduced into a tube of appropriate size
and counted in toto in a Packard y Counter,
for 1 min.
Treatment of mice.-In some groups 1 mg
live BCG was injected i.v. 2 weeks before
the labelled cells. BCG was kindly provided744 S. ORBACH-ARBOUYS, J. LHERITIER, M. ALLOUCHE AND P. POUILLART
by the Pasteur Institute under the form
"Immuno BCG" which keeps 95% of its
viability for 3 months at 4°C.
The cobra venom factor (CVF) was
purchased from Cordis Laboratories, Miami,
Florida, and given at high or low doses
according to different protocols.
Trypan blue from Fluka was dialysed
for 48 h against distilled water, lyophilized
and resuspended at a concentration of
10 mg/ml in 0-15M NaCl. The mice received
4 mg i.p. 24 h and 1 mg i.p. 3 h before the
injection ofthe cells.
Cell-free dialysates have been prepared
as follows: L1210 cells or normal spleen and
liver cells mixed in equal quantities were
suspended in Hanks' solution at the con-
centration of 5 X 107 cells/ml. They were
frozen and thawed twice and dialysed
overnight at 4°C against twice their volume
of RPMI 1640 medium pH 7 0.
Cytotoxic activity of the serum.-Blood
of normal mice was taken by orbital punc-
ture. The sera were individually tested for
cytotoxicity against L1210 cells with com-
plement according to Boyse, Old and
Chouroulinkov (1964).
Statistical analysis of the results.-The
radioactivity of the mice was plotted in
a histogram. It showed the existence of
two generally well distinct groups. The x2
test (with Yates' correction for small num-
bers) was used to compare different protocols.
We also used Wilcoxon's test which does
not require any hypothesis on the studied
distributions: all the observations are ranked
in increasing order, the comparisons being
made between the ranks of the values of
radioactivity counts after 2 different
treatments.
RESULTS
Kinetics of cell destruction in normal mice
In our experiments 107, 5 x 106,
2 X 106 or 4 x 105 labelled cells were
injected into mice which were counted in
toto at different times after the cell
injection.
It appears that 2 types of elimination
may be observed: in some animals, the
radioactivity stays at a high level, in
others, the drop is visible by 3 h after cell
injection.
A histogram was drawn, plotting the
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FIG. 1.-Distribution of the radioactivity
values in normal mice injected i.p. with
107 125IUdR-labelled leukaemic cells. Each
animal is represented by one square. The
bimodal distribution, clearly visible at 24
h, is already distinguishable at 3 h (except
for 2 mice, one represented by the empty
square in the lower group at 3 h and one,
by a star).
values of radioactivity of the mice imme-
diately after the injection, and 3 and
24 h later (Fig. 1). Progressivefy, 2
peaks are clearly visible. The separation
remains 48 h after the cell injection.
The rapid drop stops between 24 and
48 h. When the radioactivity is measured
every day, the proportional decrease is
then fairly similar in the 2 groups
(Fig. 2).
In the following discussion, the group
with a high rate of immediate cell de-
struction will be referred to as "high
responder", the group with a low rate
of cell destruction as "low responder".
The histogram of the survival time
is approximately Gaussian but within
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FIG. 2.-Release ofradioactivity after i.p. in-
jection of 107 125IUdR-labelled L1210 cells
into normal mice. The solid line represents
the mean of the mice in which the radio-
activity stayed at high values at 24 h in
the experiment reported on Fig. 1. The
broken line represents the mean of the
remaining mice: it can be seen from this
that the intense cell lysis stops before 24 h.
it, the mice which were the last to die
were usually those in which the labelling
had diminished rapidly.
Influence of the sanitary environment of the
mice
As we noticed variation from one
experiment to the other in the proportion
of high and low responders in controls,
we looked for a correlation with their
sanitary condition. When mice were in-
jected immediately after their receipt
from the pathogen-free breeding centre,
and when their sanitary environment
was satisfactory, very few mice had a
high rate of cell destruction. When they
were kept for a few weeks in our con-
ventional rooms where some latent con-
tamination existed, as can be detected
by a moderate increase in the spleen
weight, the number of mice with a high
rate of cell destruction was greater
(Table I).
Influence ofthe size ofthe inoculum
The influence ofthe size ofthe inoculum
on the number of high-responder mice
was evaluated in groups of 10 DBA/2 miceinjected with 107, 2 x 106 or 4 X 105
cells. The results on Day + 1 are reported in Table II.
Both X2c and Wilcoxon's tests show
that the number of mice in which an
early high tumour cell destruction is
observed is significantly lowest in the
groupinjected with the smallest inoculum.
Influence ofadjuvant treatment
Half the mice were injected 2 weeks
before the test with 1 mg i.v. of fresh
live BCG. They were all injected with
107 cells.
The intense immediate decrease in
radioactivity can be seen in 1/25 normal
mice and in 4/24 BCG-treated animals.
TABLE I.-Influence of the Sanitary Environment of the Mice on % ofHigh Responders
Sanitary
environment
Good
Good
Good
Good
Latent contamination
Latent contamination
High Low % of high
responders responders responders
3 32
1 24 l 9
1 11 r
4 25 J
20 28 42
12 7
TABLE II.-Influence ofSize of Inoculum on Number of High and Low Responders
Nurnber of
injected cells
4 x 105
2 x 106
107
High Low
responders responders x2c test Wilcoxon test
1 9 X2c =3-52 P 01
6 4} p 0 5 l,X2C=3.52 0 02 }6, 0-05 4
02 6 4
When the two groups which had received 2 x 106 and 107 cells were pooled, and compared to the one which has received 4 x 105 cells, X2c = 6-66 and P = 0-01.
Expt.
No.
1
2
3
4
5
6
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The x2 test is not significant, but the
Wilcoxon test indicates (P 0.05) that
the cell loss in the BCG-treated group is
statistically greater than in controls.
Cytotoxicity of the sernum
Blood was taken from untreated normal
mice just before the injection of 107
125IUdR-labelled LI210 cells. The serum
cytotoxicity against Li 210 cells was
measured individually in 10 high re-
spoinders and in 10 low responders. Speci-
fic mouse-serum-induced lysis was cal-
culated by subtracting the complement
control value from the percentage cyto-
toxicity observed with mouse serum plus
complement, dividing by 100 minus the
complement control and multiplying by
100. No noticeable difference was found
between the 2 groups; no individual
serum showed a specific lysis exceeding
1000 at the 1 : 4 dilutioin.
Cytotoxic effector cells
In order to evaluate the eventual
cytotoxic role of the macrophages, we
chose to use trypan blue (Hibbs, 1975)
5- Controls
E 5 10 15 20
E10
5-
Trypan blue
I r-ln r
5 10 15 20
ct/minxio-2 at 24h
Fim: 3. Effect of trypan-blue treatment. All
the animals have ieceived I mg 1(3'G 2
weeks before the 2 x 106 1254TUdR-labe?lled
L1210-cell injection. The trypan blute-
treated animals have beeni injected i.p. -with
4 mg trypan blue 24 h ain(d 1 mg 3 h befor-e
the cell injection; the group in which the
cell destructioni w%-as intense is importanlt in
the control animals ain(l neairly absent in the
tiypain blue treated mice. X2 betw%reen
tryplan blue aIlnd control 21 85 (P < 00001).
which inhibits very specifically their
cytotoxic activity.
In this experiment we pretreated all
the animals with BCG and injected
2 x 106 L1210 labelled cells in order to
increase the proportion of high-responder
mice, so that an eventual inhibition of
the tumour-cell destruction could appear
more evident. The result of the trypan-
blue treatment was to suppress almost
entirely the high responder group (Fig. 3)
and significantly to shorten the survival
of the mice (the x2 comparing the number
of surviving animals in the control and
untreated group on Day 12 is highly
significant: X2 1175, P 0 O001).
We checked whether the trypan-blue
treatment could modify the eliminatioin
of the label of the lysed cells. A dose of
adriamycin (10 mg/kg) which efficiently
kills the L1210 cells, was injected into
trypan-blue-treated mice. Most of the
radioactive label was eliminated within
a few hours, exactly as in non-trypan-
blue-treated mice.
Since macrophages from the labelled
L1210-cell donor might play a role in
the cytotoxicity observed in high-
responder animals, we inhibited, in one
experiment, these macrophages by treat-
ing the donors with trypan blue 24 h
before harvesting tumour cells and in-
jecting them into the recipients. Untreated
donor animals were used as controls.
The percentage of high responders was
nearly the same in the 2 groups.
The amount of non-leukaemic cells in
the inoculum was also evaluated; it has
never been found to be more than 10%
macrophages and 2% polynuclear cells.
Role of C3b component of complement
The injection of high doses of cobra
venom factor (250 u/kg in 4 equal i.p.
injections at 8h intervals within a
24h period) is known to reduce the
serum C3 level by more than 9500 for
more than 48h (Pepys, 1972). Tumour
cells were injected at this time: it canii
be seen (Table III) that in 2 experiments
the number of high-responder mice isIN VIVO DESTRUCTION OF TUMOUR CELLS
TABLE III. Influence of the Pretreatment of Mice by High Doses of Cobra Venom Factor
(COVF) (250 u/kg) on the Number of High and Low Responders
Number of
injecte(l cells Treatment
107 Control
107 CVF
2 x 106 Corntrol
2 x 106 CVF
High Low
respon(lers responders X2C test
5 25 } 3 66
0 31
11, 8 3} 8 5 14 38
TABLE IV. Effect of Low Doses of Cobra Venom Factor* on the Nubmber of
High and Low Responders
High Low
Treatmeint respon(lers respondlers
Controls 6 24
50 u/kg 7 23
12-5 u/lkg 16 14
5 u/k-g 14 16
x2 test
}NS X2=7-2 1
rP= 0-01 X2 =4-8
P = P0-03
Wilcoxon test
}NS}=0.02
}P
* Tinjecte(l at the same time as the cells.
TABLE V.-Influence of the Injection of Tumiour or Normal-cell Dialysates on the Number
of High and Low Responders
Treatmenit
Controls
Tumour-cell dlialysate
Normal-cell dialysate
(spleen+liver)
significantly lower in the CVF-treated
group than in the controls.
In another experiment, we moderately
enhanced the production of the C3b
component by low doses of CVF (5-50
u/kg) given i.p. at the time of the cell
injection: it can be seen (Table IV) that
for the lowest two doses the number of
mice in which the destruction is high
is significantly greater than in the saline-
injected group.
Effect of tumour- and normal-cell dialysates
Mice received two i.p. injections of
01 ml, either of tumour-cell dialysate, or
of normal spleen and liver-cell dialysate,
or of RPMI 1640 medium: the first
injection was given 90 min before to the
cells, the second at the time ofthe 5 x 106
cells injection.
The proportion of high and low re-
sponders in the 3 groups are given in
Table V. It can be seen that the dialysates,
either of tumour cells or of normal
50
High Low
responders responders
4 38 X x2 16-5
21 20 JP<0O0001 X°=641
x2=2-89 rP= 0-02
13 27 fP 0-09 J
cells, significantly increase the number
of high responders. However, the effect
of the tumour-cell dialysate is much
greater than that ofnormal-cell dialysates,
the difference between these two effects
nearly achieving statistical significance
(P
= 0.09).
DISCUSSION
The kinetics of destruction of tumour
cells injected i.p. into mice can be studied
by prelabelling these cells and measuring
the in toto animal radioactivity. The
radiation ofthe 1251, which is incorporated
into cellular DNA, is easily detectable
through the tissues. When tumour cells
are destroyed, DNA and its metabolites
are eliminated, mainly in the urine.
So the 125IUdR-labelling method provides
a simple means of assaying in vivo the
death of prelabelled tumour cells (Hofer,
et al., 1969; Porteous and Munro, 1972; Sadler and Alexander, 1976), provided
that the labelling is kept within a range
p
0 05
0 05
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which does not interfere with the normal
physiology of the cells (Reif and Kim,
1971; Norbury and Fidler, 1975). The
rate of the loss of radioactivity is pro-
portional to the rate of cell killing.
The tumour line chosen is the chemic-
ally induced ascitic leukaemia L1210.
When the cells are injected into DBA/2
(the original strain for the tumour) or Fl
(DBA/2 x C57BL/6) mice they remain
mostly in the peritoneal cavity.
When normal healthy mice are injected
with labelled tumour cells, we observed,
in a certain number of animals, an
intense destructive capacity, while in
the others the cell destruction is low.
In the group with a high destruction
rate the number of cells which are killed
may be higher than 7500, even after
injection of the 107 cells. This destruction
is very rapid and already visible within
3 h. In spite of the high number of cells
destroyed, death of the animals is only
slightly delayed and no mouse survived:
some form of regulation prevents the
mechanism from being entirely efficient.
It can be seen (Fig. 2) that the high
cell-destruction rate has nearly finished
within 24 h.
We are thus dealing with the existence
of two groups of animals: one in which
the tumour-cell destruction is low and
one in which it is intense. These groups
have been referred to as low and high
responders. The different treatments given
to the mice only displaced the animals
from one group to the other; we rarely
observed intermediate values.
If we consider a given group of animals
we could explain the existence of high
and low responders by a pre-existing
heterogeneity or by one induced by the
animal manipulation such as a cage
effect or a leakage at the site of cell
inoculation. To avoid this, we used mice
of the same delivery, same age, random-
ized and very carefully injected. When
we compare different groups of control
or treated mice, if heterogeneity remains
it is distributed at random between the
groups and cannot by itself create a
significant difference between them. If
such a difference appears, and if it is
reproducible, it should be attributed to
the treatment.
There is much literature on the non-
specific cytotoxic effects against tumour
cells. The transfer of the animals from an
SPF environment to conventional condi-
tions can induce the formation of
heterophile and homophile antibodies,
cross-reacting with various tumour cells.
Natural and opsonic antibodies against a
certain number of tumour lines have
also been detected in the sera of all
mouse strains. Some authors have also
described a non-specific cell-mediated
cytotoxicity by "natural killers" or by
lymphocytes: "spontaneous lymphocyte-
mediated cytotoxicity". Most of these
studies are based on in vitro experiments.
It is thus difficult to assert, without
furtherexploration, thatthey couldexplain
the intense in vivo cytotoxicity observed
here, the more so as none of these authors
has noticed a bimodal distribution of
their observations in the cases where
the individual cytotoxicity was measured.
We have measured the cytototoxicity
of the serum of high- and low-responder
mice and have not detected any correla-
tion with the in vivo response. These
results are in agreement with those of
different authors. Pierotti and Colnaghi
(1975) and Martin and Martin (1975)
demonstrated that the level of natural
antibodies against various syngeneic tu-
mour lines in the serum of the DBA/2
and the C57BL/6 strains is low. Martin
and Martin (1975) found that in the
DBA/2 strain, the cytotoxicity of the
serum against the L1210 ascitic cells was
<2000. Menard, Colnaghi and Della
Porta (1977) and Pierotti and Colnaghi
(1976) showed that natural antibodies
are not detectable before the age of 12
weeks (i.e. mice older than the animals
we have used).
In the search for an effector cell, we
treated mice with trypan blue, which
specifically inhibits macrophage lysoso-
mal-enzyme cytotoxic activity (Hibbs,IN [VIVO DESTRUCTION OF TUMOUR CELLS
1975) and we observed that, after this
tieatment, the high-responder group dis-
appears almost entirely. This is not due
to an alteration of the clearance of the
label since, in try)an blute-adriamycin-
treated animals, the elimination of the
radioactivity is very rapid after t,he cell
destructioin by the drug.
We have already seen that the role
of the few macrophages present in the
inoculum, which might have been held
responsible for some of the cytotoxic
activity, canI be ruled out. We can there-
fore conclude that the recipient's macro-
phages are inivolved in the ex)ression
of the cytotoxicity described here.
The tumour-cell lysis observed has
the characteristic of an "all or nothing"
phenomenon, suggesting the existence of
a self-perpetuating reactioin: this sup-
poses that the trigger might be the same
factor as the end product, which in its
tuirn becomes the trigger: the reaction
keeps oIn going until some factor stops it.
Among such positive feedback reactions,
the amplification phase of complement
activation can be considered as being
possibly responsible for our observations,
the trigger being the C3b component.
This hypothesis is confirmed by the
results of the CVF experiments. XVhen
high doses of CVF are given, the C13
fraction is largely depleted at the time
of the cell injection, and the formation
of C3b by cleavage of C3 is very limited.
The amplification loop of the complement
activation cannot be triggered.
On the contrary, CVF given at low
doses at the time of the cell injection is
an activating factor which, through dif-
ferent stages, initiates the chain reaction
without depleting the pool of C3 com-
poinen-it.
A positive feedback reaction within
macrophages has been shown in vitro
and in vivo (Bentley et al., 1976; Bitter-
Suermain et al., 1976; Schorlemmer and
Allison, 1976; Brade et al., 1974).
The C3 feedback cycle requires C3
and factors B and D. The first two
are produced bv macrophages; proteo-
lytic enzymes are able to replace factor
D, the role of which is to activate C3bB
into C3bB which cleaves C3. Macrophages
thus possess, within themselves, all the
components of the alternate pathway
reaction.
The tumour-cell lysis could be explained
by transfer of lysosomal enzymes of
such stimulated macrophages (Hibbs,
Lammert and Remington, 1972; Hibbs,
1975).
The tumour-cell lysis could also be
attributed to the C3a component produced
with the C3b (Ferluga et al., 1976). C3a
also has a chemotactic role, attracting
the macrophages to the tumour site.
In a recent paper, Pike and Snyderman
(1976) described the preparation of a
factor produced by neoplasms, a factor
found to be an activator of tumour
growth. It seemed interesting to prepare
an extract of the LI210 line according to
their method and to test it in our model.
The results show a completely opposite
effect: the dialysable factor of tumour
cells significantly increases the number
of high responders; the different effects
of Pike's and our dialysates can be
explained by the different site ofinjection;
contrarv to our experiment, Pike gives
the dialysate at a site distant from the
inoculation of the tumour.
The chain reaction in the high re-
sponders very probably starts at the time
of cell injection; it may be possible that
products released by these cells initiate
the alternative pathway loop; the tumour-
cell dialvsate could contain such sub-
stances.
Dialysate of normal cells can to a
lesser extent also trigger the reaction;
further studies are required to define
the factors responsible for the enhanced
activity. In conclusion, the early intense
in vivo destruction of syngeneic tumour
cells seems to imply the participation
of the macrophages, of the cleavage
products of C3, and of some tumour-cell
components as trigger of the reaction.
It is not yet possible to extend our
conclusions to the human situation, and
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to assume that the defence mechanisms
described here play a role in cancer in
man. It must, however, be noted that
many products are known to enhance
the alternate pathway of complement
activation, among which some are used
as adjuvants as, for instance, LPS.
An activation of complement in patients
submitted to immunotherapy by Coryne-
bacterium parvum, leading to a fall in
the C3 serum titre and in the appearance
of C3 proactivator has been reported
immediately after the C. parvum injection
(Biran et al., 1976).
This work was supported by an
INSERM grant No. 75-5-096-1 and a
CNRS grant No. 2298.
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